erythropoietin
erythropoietin
1. Serum C-reactive protein predicts erythropoietin resistance in hemodialysis patients
C-反应蛋白水平与血液透析患者贫血和促红细胞生成素抵抗的关系
2. Erythropoietin producing hepatoma cell
Eph受体酪氨酸激酶A2
3. erythropoietin receptor gene
EPOR基因
4. Prof.Pawlotsky: Well you have to inform the patient, you have to be present when they suffer, and you might have to eventually use growth factors such as erythropoietin (EPO) in these patients.
Pawlotsky教授：你要告知患者，你要在他们痛苦时安慰他们，最终你可能还要对他们应用生长因子例如促红细胞生成素。
5. , on an anti-anemia drug based on the protein erythropoietin (EPO).TKT had used a type of DNA gene switch to make EPO.
TKT使用一种DNA基因开关来制造红血球生成素，但是为了让这个蛋白具有疗效，TKT必须将该蛋白从制造的细胞株里纯化出来；
6. One is erythropoietin (epo), it can improve the training and endurance training load, but it may cause thrombosis, endangering the lives of athletes of prohibited substances.
一个是促红细胞生成素（epo），它能提高训练耐力和训练负荷，但可能造成血栓，危害运动员生命的违禁物质。
7. Children less than two years old with a high concentration of erythropoietin were least likely to suffer neurological problems after cerebral malaria.
不足两岁有着大量促红血球生长素的孩子在得了脑型疟疾后患神经系统疾病的可能性最小。
8. Ortho Biotech, for example, recently changed one of the chemicals added to its erythropoietin alpha medicine as a stabilizer.
举例来说，美国奥多生物科技公司最近换了加在红血球生成素里头的一种安定剂。
9. Keywords Greast milk;erythropoietin;physiological effects;
乳汁;促红细胞生成素;生理作用;
10. Cloning of Human Erythropoietin Genomic Gene and cDNA and Expression in COS-7 Cells
人促红细胞生成素基因组基因和cDNA的克隆及其在COS－7细胞中的表达
11. Keywords total saponins of panax ginseng （TSPG）;erythropoietin receptor （EPOR）;mononuclear cells（MNCs）;
人参总皂苷（TSPG）;红细胞生成素受体（EPOR）;单个核细胞;
12. The Analysis and Identify of Characteristics for the Engineering Cell Lines of Erythropoietin
人红细胞生成素工程细胞株的特性鉴定
13. Effects of statin and erythropoietin on the number and function of endothelial progenitor cells derived from human peripheral blood
他汀类药物和促红细胞生成素对人外周血内皮祖细胞数量和功能的影响
14. Gene transfer to raise erythropoietin production has already been tried in animals, with results that illustrate the potential dangers of prematurely attempting such enhancements in humans.
以基因转植增加红血球生成素，已进行过动物试验，结果显示如果贸然在人体尝试，将会引发潜在的危险。
15. Effects of acute hypoxia and intermittent hypoxic acclimatization on erythropoietin gene expression in rat hepatic and renal tissues
低氧对肝肾组织内红细胞生成素基因表达的影响
16. Expression of erythropoietin and its receptor in human RPE cells induced by chemical hypoxia
低氧诱导促红细胞生成素及其受体在人胚胎RPE细胞中的表达
17. Reduction of endogeneous erythropoietin concentration causes immediate suppression of ERC differentiation, but the influence on E-CFU-D is not instantaneously displayed as observed in ERC.
体内EP浓度降低时,ERC的分化受阻,但是,EP对E-CFUweD分化的影响却介于ERC与原红细胞之间。
18. Higher doses of erythropoietin have been associated with tumor growth, and without careful dosing and timing, treatment might exacerbate pathologic angiogenesis, write the authors.
作者写道，高剂量的红血球生成素已经被证实与肿瘤生长有关，且在没有仔细调整剂量与使用时机的情况下，治疗可能加剧病理血管新生；
19. Keywords dependovirus;erythropoietin;gene expression;gene therapy;
依赖病毒;红细胞生成素;基因表达;基因治疗;
20. Effects of the recombinant human erythropoietin on the lipid disorders of chronic renal failure
促红素对慢性肾功能不全脂质紊乱疗效的实验研究
21. Recombinant human erythropoietin(rh-epo)
促红细胞生成素
22. When the aneamia in these patients is treated with erythropoietin(EPO), a significant improvement is obtained in both the aniamia and cardiac function.
促红细胞生成素(EPO)不仅改善贫血,同时改善心功能不全患者的左心室功能,提高生活质量。
23. Erythropoietin (EPO) has been viewed traditionally as a hematopoietic cytokine produced by the fetal liver and adult kidney in response to hypoxia.
促红细胞生成素(EPO)传统上被认为是由胎儿肝脏和成人肾脏对缺血起反应的造血因子。
24. Erythropoietin (EPO) has neuroprotective effects.It plays a key role in cerebral ischemia and subarachnoid hemorrhage via mechanisms, such as apoptosis and scavenging free radicals, etc.
促红细胞生成素(EPO)具有神经保护作用,在缺血性脑损伤和蛛网膜下腔出血等中枢神经系统损伤中发挥保护作用的机制有多种,如抗细胞凋亡和清除自由基等。
25. Erythropoietin(EPO) is known as a classical hematopoietic growth factor of cells,which has been used to treat anemia caused by different reasons.
促红细胞生成素(EPO)是一种造血细胞生长因子,以往主要用于治疗多种原因所致的贫血。
26. Keywords erythropoietin;chronic renal failure;erythroid pro-genitor cell;
促红细胞生成素;慢性肾衰竭;骨髓红系祖细胞;
27. Keywords erythropoietin;cerebral ischemia;neurons;a poptosis;necrosis;rat;
促红细胞生成素;脑缺血;神经元;凋亡;坏死;
28. Keywords erythropoietin;L-carnitine;nandrolone phenylpropionate;hemodialysis;anemia;
促红细胞生成素;苯丙酸诺龙;左卡尼汀;血液透析;贫血;
29. Keywords Erythropoietin Non-small cell lung cancer Anemia;
促红细胞生成素;非小细胞肺癌;贫血;
30. Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats.
促红细胞生成素与一氧化氮合酶抑制剂对肝硬化大鼠高动力循环状态的影响。
31. Erythropoietin (EPO) has mature techniques from production to clinical application, and has effects of anti-apoptosis and reducing inflammatory reaction.
促红细胞生成素从生产到临床使用技术都很成熟，具有抗凋亡和减轻炎症反应的作用。
32. As a traditionally hematopoietic factor,Erythropoietin(EPO)has other important biologic effects besides hematogenesis.
促红细胞生成素作为一种传统意义上的造血生长因子,有着造血作用以外的重要生物学作用。
33. Erythropoietin, as well as its receptor, is present in the central and peripheral nervous system.
促红细胞生成素及其受体在中枢神经和周围神经均有存在。
34. Erythropoietin receptor (EPO-R)
促红细胞生成素受体
35. erythropoietin receptor antibody
促红细胞生成素受体抗体
36. Effect of angiotensin-converting enzyme inhibitor on erythrocyte of erythropoietin treated hemodialysis patient
促红细胞生成素和血管紧张素转换酶抑制剂对血透患者贫血的影响
37. Effect of recombinant human erythropoietin on vasoactive substances in aged maintenance haemodialysis patients
促红细胞生成素对老年血液透析患者血管活性介质的影响
38. Erythropoietin,the principal regulator of erythroids progenitor cells,is widely used to treat anemia caused by many diseases.
促红细胞生成素是一种造血因子,临床中广泛应用于治疗各种原因造成的贫血。
39. Clinical investigation of anemic premature birth infants treated with erythropoietin
促红细胞生成素治疗早产儿贫血的临床研究
40. Erythropoietin therapy for anemic patients with non-small cell lung cancer in combination chemotherapy
促红细胞生成素治疗晚期非小细胞肺癌化疗所致的贫血
41. Clinical Evaluation of Erythropoietin Therapy for Anemic Patients with Non-small Cell lung Cancer After Chemotherapy
促红细胞生成素治疗晚期非小细胞肺癌化疗相关贫血的临床观察
42. Apart from the red cell surface, erythropoietin's receptor (Epo-R) is also expressed in a large variety of normal tissues.
促红细胞生成素的受体除分布在红血球表面外，也在大批正常组织表达。
43. Paoletti E, Cannella G.Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease?J Am Soc Nephrol 2006，17(Suppl 2):S74-S77.
倪兆慧，钱家麒，丁小强，等.蔗糖铁注射液治疗维持性血液透析患者肾性贫血的前瞻性随机对照多中心研究.中华肾脏病杂志2006，22：143-148.
44. Keywords recombinant human erythropoietin;renal anemia;chronic renal failure;middle and old aged patients;
关键词红细胞生成素;肾性贫血;慢性肾功能衰竭;中老年患者;
45. Keywords cytokine;peptides mimetic/non peptides mimetic;erythropoietin;thrombopoietin;phage display peptide library;
关键词细胞因子;肽类/非肽类模拟物;红细胞生成素;血小板生成素;噬菌体展示文库;
46. Keywords Spirulina platensis;C-phycocyanin;erythroid progenitor cells;erythropoietin;
关键词钝顶螺旋藻;藻蓝蛋白;红系祖细胞;促红细胞生成素;
47. The pathogenesis related to the erythropoietin secretion from malignant tumors, while another factor might be the immunological disturbance of T-lymphocyte caused by thymoma.
其发病机制与恶性肿瘤分泌促红细胞生成素有关,也可能是胸腺瘤所致T细胞免疫功能紊乱所致。
48. Relationship of erythropoietin with blood rheology and hemocyte parameters in patients with coronary heart disease
冠心病患者血清促红细胞生成素与血液流变学及血细胞参数的关系
49. In 1990, another way of increasing the level of haemoglobin, was the use of erythropoietin(EPO) and was included in the IOC's list of prohibited substances.
另一种增加血红蛋白含量的方法是使用促红细胞生成素，1990年国际奥委会也将其列入了被禁药物名单。
50. erythropoietin soluble receptor
可溶性促红细胞生成素受体
51. Unlike many biotechnology companies, 3SBio is profitable, largely because of its key product, EPIAO, an injectable recombinant human erythropoietin.
同许多生物技术公司不同的是，三生制药是盈利的，这主要是因为该公司的核心产品益比奥（重组人红细胞生成素）。
52. Mcnabon LP,Dawborn JK.Experience with low dose intranvenous and subcutaneous administration of recombinant human erythropoietin[J].Am J Nephol,1990,10(3):404.
吴俊,袁志忠,叶朝阳,等.大剂量重组人红细胞生成素治疗尿毒症贫血的疗效观察[J].第二军医大学学报,2002,23(11):1243.
53. Randomized multicentre trial of the influence of recombinant human erythropoietin on the perioperative patients
围手术期应用重组人红细胞生成素的多中心随机对照研究
54. The Preventive Effects of Recombinant Human Erythropoietin on the Anemia of Premature Birth Infant
国产重组人类促红细胞生成素预防早产儿贫血
55. Hepatology Digest: What about in China and the use of erythropoietin?
国际肝病：在中国促红细胞生成素的应用如何？
56. When anemia in these patients is treated with erythropoietin(EPO),a significant improvement in cardiac function and symptoms was observed.
在这些患者的贫血用促红细胞生成素(EPO)治疗时,能观察到其心功能和症状明显改善。
57. Pharmacokinetics of multi - dosing subcutaneous injections of recombinant human erythropoietin in human
多剂量皮下注射重组人促红细胞生成素在健康人体的药代动力学
58. A RESEARCH ON CHANGE OF THE LEVELS OF SERUM ERYTHROPOIETIN AND FREE TESTOSTERONE AFTER BIG BURTHEN SWIMMING
大负荷游泳训练后血清促红细胞生成素、游离睾酮变化的研究
59. Alteration of Erythropoietin Expression in Rats after Intensive Training Load
大运动负荷训练及恢复后大鼠促红细胞生成素表达的变化
60. This research presented a modified two-phase chloramine-T method for radioiodine labeling of protein and Long-lasting Erythropoietin(LL-EPO) was labeled.
对双相氯胺-T碘标法实验装置作了改进并标记长效促红细胞生成素(LL-EPO),采用离心超滤技术代替传统的柱层析脱盐纯化标记蛋白质。
61. The most frequent causes of PTA were erythropoietin (EPO) and iron deficiency.
导致PTA最常见的原因是红细胞生成素（EPO）和缺铁。
62. Keywords Intrauterine fetal growth retardation;Erythropoietin（EPO）;Nucleated red blood cell;
小于胎龄儿;促红细胞生成素;有核红细胞;
63. Clinic study of erythropoietin therapy and autohemotherapy in the child cardiac operation
小儿心脏手术促红细胞生成素治疗和术前自体献血的临床研究
64. Expression of brain-derived erythropoietin in the hippocampus of low dose 3-NPA preconditioned gerbils
小剂量3-硝基丙酸预处理后鼠脑海马脑源性促红细胞生成素的表达
65. The Clinic Treatment Effect of L-Carnitine and Erythropoietin on Anemia of Chronic Renal Disease
左卡尼汀和红细胞生成素治疗肾性贫血的临床观察
66. To integrate L-carnitine with erythropoietin can improve maintenance hemodialysis patients'dialysis tolerance
左旋卡尼汀与红细胞生成素合用可提高维持性血液透析患者的透析耐受性
67. To integrate L-carnitine with erythropoietin can improve maintenance hemodialysis patients'quality of life
左旋卡尼汀联用红细胞生成素对维持性血液透析患者生活质量的影响
68. Effect of Simulated HiLo Training on Serum Erythropoietin and Related Indexes of Erythrocyte in Rats
常压模拟高住低练对大鼠促红细胞生成素及红细胞相关指标的影响
69. Effects of stem cell factor in combination with erythropoietin on erythropoiesis in patients with anemia associated with non-Hodgkin's lymphoma
干细胞因子与促红细胞生成素联合应用对非霍奇金淋巴瘤贫血患者红系生成的作用
70. Pharmacokinetics of recombinant human erythropoietin produced by baby hamster kidney cells in rhesus monkeys
幼仓鼠肾细胞表达重组人红细胞生成素在猕猴中的药动学
71. ectopic erythropoietin syndrome
异位红细胞生成素综合征
72. ectopic erythropoietin secretion
异源红细胞生成素分泌
73. Multi-analysis of factors affecting erythropoietin level of umbilical blood
影响脐血促红细胞生成素水平的多因素分析
74. The expression of erythropoietin receptor in the spinal cord after acute traumatic injury in adult rats
急性脊髓损伤后促红细胞生成素受体的表达及其意义
75. Clinical significance of endogenous erythropoietin change in patients with acute cerebral infarction
急性脑梗死患者内源性红细胞生成素的变化及临床意义
76. Keywords Chronic disease;Iron deficiency anemia;Erythropoietin;Serum transferrin receptor;
慢性病;缺铁性贫血;红细胞生成素;血清转铁蛋白受体;
77. Comparison between serum erythropoietin levels in patients with anemia of chronic diseases and iron-deficiency anemia
慢性病贫血与缺铁性贫血患者血清红细胞生成素水平比较
78. Clinical study of the effects of recombinant human erythropoietin on left ventricular hypertrophy in chronic renal insufficiency patients with anemia
慢性肾功能不全患者纠正贫血对逆转左心室肥大的观察
79. Study of Correlation between Serum Erythropoietin and Hemoglobin in Anemic Patients of Chronic Renal Failure
慢性肾衰患者促红细胞生成素与血红蛋白的相关性研究
80. Effect of secondary hyperparathyroidism on the response to erythropoietin in chronic renal failure
慢性肾衰甲旁亢对红细胞生成素疗效的影响
